Live Analyst Rating Changes 1505 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Michael Cherny
LP
Michael Cherny
Wall Street Analyst
★★☆☆☆
#2029
on 13Foresight · ranked by our own returns
42%
Success Rate
-2.8%
Average Return
13 of 31 calls profitable · -11.6% vs benchmark
📈 Across the calls we could measure, roughly 42% of Michael Cherny's ratings turned a profit when each position was held for 1 year — averaging -2.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

71 Buy 41 Hold 0 Sell
Michael's Stock Coverage 29 ratings · 2026-06-18
Company Date Position Consensus Price Target 1-Yr Return
CERT
Certara
Jun 16, 2026 BUY Buy
+117.0% avg upside
21 analysts
$8.00
32.60% Upside
+0.0%
MDLN
Medline
Jun 12, 2026 BUY Strong Buy
+41.3% avg upside
26 analysts
$52.00
42.83% Upside
-1.8%
XRAY
DENTSPLY SIRONA
Jun 12, 2026 HOLD Buy
+177.1% avg upside
25 analysts
+4.8%
ICLR
Icon
May 28, 2026 HOLD Strong Buy
+26.2% avg upside
25 analysts
$145.00
1.28% Upside
+8.0%
ALGN
Align Tech
May 27, 2026 BUY Strong Buy
+62.9% avg upside
21 analysts
$230.00
32.64% Upside
+6.5%
DOCS
Doximity
May 15, 2026 BUY Buy
+61.4% avg upside
27 analysts
$25.00
22.28% Upside
+9.0%
HIMS
Hims & Hers Health
Apr 16, 2026 HOLD Buy
-22.4% avg upside
22 analysts
+0.7%
CVS
CVS Health
Mar 24, 2026 BUY Strong Buy
+2.5% avg upside
38 analysts
$98.00
1.24% Downside
+39.6%
HSIC
Henry Schein
Feb 24, 2026 HOLD Buy
+7.3% avg upside
25 analysts
$87.00
8.74% Upside
-2.6%
NVST
Envista Holdings
Feb 06, 2026 BUY Buy
+16.9% avg upside
19 analysts
$35.00
40.84% Upside
-20.2%
WAY
Waystar Holding Corp.
Feb 02, 2026 BUY Strong Buy
+108.2% avg upside
29 analysts
$43.00
135.56% Upside
-30.1%
CAH
Cardinal Health
Jan 13, 2026 BUY Strong Buy
-13.9% avg upside
29 analysts
$240.00
5.99% Upside
+8.9%
IQV
IQVIA Holdings
Dec 14, 2025 BUY Strong Buy
+33.0% avg upside
38 analysts
$256.00
49.95% Upside
-20.2%
DGX
Quest Diagnostics
Oct 22, 2025 BUY Buy
-13.1% avg upside
33 analysts
$210.00
6.20% Upside
+13.5%
ACH
Accendra Health
Oct 09, 2025 HOLD Hold
+449.1% avg upside
17 analysts
$6.00
89.78% Upside
-54.4%
MEDP
Medpace Holdings
Oct 08, 2025 HOLD Buy
-11.5% avg upside
16 analysts
$490.00
7.23% Upside
-12.0%
LH
Labcorp Holdings
Oct 08, 2025 BUY Strong Buy
+0.7% avg upside
36 analysts
$342.00
31.74% Upside
-7.1%
MCK
McKesson
Oct 06, 2025 BUY Strong Buy
-4.5% avg upside
27 analysts
+4.8%
COR
Cencora
Oct 06, 2025 BUY Buy
+13.1% avg upside
43 analysts
$361.00
30.25% Upside
-7.1%
GDRX
GoodRx Holdings
Oct 02, 2025 BUY Buy
+389.3% avg upside
28 analysts
-41.0%
PGNY
Progyny
Oct 01, 2025 BUY Strong Buy
+10.8% avg upside
14 analysts
+22.1%
TDOC
Teladoc
Jul 30, 2025 HOLD Buy
+278.2% avg upside
37 analysts
$7.50
1.26% Downside
-4.2%
VRTX
Vertex Pharmaceuticals
Dec 20, 2024 BUY Strong Buy
-3.9% avg upside
61 analysts
$542.00
18.18% Upside
+14.8%
DD
DuPont de Nemours
Sep 04, 2024 HOLD Strong Buy
+50.7% avg upside
26 analysts
-3.6%
TSE:TRX
Tanzanian Royalty Exploration
Jul 08, 2024 BUY Strong Buy
+149.1% avg upside
4 analysts
·
SONX
Sonendo
Jul 11, 2023 BUY Buy
+1875.0% avg upside
5 analysts
$3.00
400.03% Upside
·
MDRX
Veradigm
Jun 14, 2023 BUY Buy
+207.0% avg upside
22 analysts
$21.50
347.98% Upside
-21.6%
GOCO
GoHealth
May 11, 2023 SELL Hold
+4154.1% avg upside
12 analysts
$11.00
3506.47% Upside
+38.5%
AMWL
American Well
Jan 05, 2022 HOLD Hold
+61.9% avg upside
15 analysts
$7.50
11.68% Downside
-37.7%
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Michael Cherny — Frequently Asked Questions
How accurate are Michael Cherny's stock ratings?
Based on the calls 13Foresight could measure, about 42% of Michael's ratings were profitable over a one-year hold, with an average return of -2.8% per rating, or -11.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Michael ranked on 13Foresight?
Michael Cherny is currently ranked #2029 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Michael cover?
Michael most recently has ratings on CERT, MDLN, XRAY, ICLR, ALGN, DOCS, HIMS, CVS, HSIC, NVST, WAY, CAH and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.